Natco Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is TERIFLUNOMIDE, with a corresponding US DMF Number 30506.
Remarkably, this DMF maintains an Active status since its submission on April 29, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 19, 2016, and payment made on May 18, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II